Showing results (41-50 of 171) with videos related to
Sort By:
Pageof 18
Cancer|October 13, 2011
Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancerDavid H Ilson, Bruce D Minsky, Geoffrey Y Ku, et al.Plos One|August 15, 2015
Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction CancerYelena Y Janjigian, Efsevia Vakiani, Geoffrey Y Ku, et al.Seminars in Radiation Oncology|December 23, 2006
Targeted agents and esophageal cancer--the next step?Mebea Aklilu, David H IlsonOncology (Williston Park, N.Y.)|October 23, 2003
Irinotecan in esophageal cancerDavid H Ilson, Bruce MinskyCurrent Treatment Options in Oncology|May 7, 2022
Approach to Resectable Gastric Cancer: Evolving Paradigm of Neoadjuvant and Adjuvant TreatmentMelissa A Lumish, Geoffrey Y KuChinese Clinical Oncology|November 14, 2017
Systemic therapy for esophagogastric cancer: targeted therapiesTomas G Lyons, Geoffrey Y KuChinese Clinical Oncology|November 14, 2017
Systemic therapy for esophagogastric cancer: immune checkpoint inhibitionTomas G Lyons, Geoffrey Y KuThe Oncologist|March 26, 2014
Management of localized esophageal cancer in the older patientElizabeth Won, David H IlsonCancer|May 7, 2016
Change in chemotherapy during concurrent radiation followed by surgery after a suboptimal positron emission tomography response to induction chemotherapy improves outcomes for locally advanced esophageal adenocarcinomaGeoffrey Y Ku, Anuja Kriplani, Yelena Y Janjigian, et al.Journal of Gastrointestinal Oncology|July 12, 2023
Perioperative versus total neoadjuvant chemotherapy in gastric cancerJessica Yang, Megan Greally, Vivian E Strong, et al.Pageof 18